Publication
Yang Y, et al. SGLT2 Inhibitor Use and Levels of Hemoglobin, Markers of Iron Metabolism, and Erythropoiesis: Meta-Analysis of RCTs. JAMA, 2026
PMID 42925557
Метаанализ 85 РКИ, 70 543 участника с ССЗ, диабетом, СН или ХБП. Гемоглобин +0,60 г/дл (95% ДИ 0,55–0,66), гематокрит +2,36 п.п. Клиническое значение неясно.
Scales
Identifiers
- PMID
- 42925557
- DOI
- 10.1001/jama.2026.19921
Original sources
Details
- Journal
- JAMA
- Year
- 2026
A catalog card describes research; it is not medical advice. Decisions about treatment are made with a doctor.